Emily M. Leproust, Chief Executive Officer of Twist Bioscience Corp (TWST), sold 113,318 shares of the company's stock on August 10, 2026. The transaction, valued at approximately $14.18 million, occurred at an average price of $125.16 per share.
This sale represents a significant divestment by a key executive. While insider sales can be driven by various factors such as portfolio diversification or tax planning, they are often monitored by investors for potential shifts in executive sentiment.
This transaction follows a series of other insider sales at Twist Bioscience in early August, including sales by Robert Chess and Dennis Cho. Investors will be observing future filings for any additional insider activity.